Tokmak, S. Et Al. 2021. What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment?. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.3 , 294-301.

Tokmak, S., , Gümürdülü, Y., Tas, D. A., Kara, I. O., Guzel, A. B., ... (2021). What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment?. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.3, 294-301.

Tokmak, Salih Et Al. "What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment?," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.3, 294-301, 2021

Tokmak, Salih Et Al. "What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment?." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.3, pp.294-301, 2021

Tokmak, S. Et Al. (2021) . "What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment?." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.32, no.3, pp.294-301.

@article{article, author={Salih Tokmak Et Al. }, title={What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment?}, journal={TURKISH JOURNAL OF GASTROENTEROLOGY}, year=2021, pages={294-301} }